Thursday, August 09, 2018
Effective technology transfer protocols share the knowledge and capability of a given API manufacturing process and lay the foundation for the next stage of development. They also enable Contract Development and Manufacturing Organizations (CDMOs) to...
As every Contract Manufacturing Organization (CMO) knows, sourcing raw materials is critical to drug development and can make or break the chances for successful commercialization. Whether the project requires off-the-shelf or customized ingredients,...
Concerned with rising R&D costs, many U.S. bio/pharma companies are considering Asian countries, such as India and China, for the development of their Active Pharmaceutical Ingredients (APIs) and pharma products, in the hope of getting a good deal, ...
While CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is
getting a lot of attention as this year’s potential wonder therapy, the generics
industry continues to undergo change. Positive change.